Volume : 13, Issue : 11, November – 2026

Title:

FORMULATION AND EVALUATION OF SAXAGLIPTIN-LOADED TRANSFEROSOMAL ORAL THIN FILMS FOR ENHANCED PERMEABILITY

Authors :

Maddela Bharani, I. Nagaraju, Dr. G. S Valluri, G Vijaya Kumar

Abstract :

The present research work on the formulation, development, and evaluation of Fulvestrant Solid Lipid Nanoparticles (SLNs) was successfully completed. Different formulations were prepared and evaluated to develop an effective sustained-release nanoparticulate drug delivery system for Fulvestrant. The prepared formulations exhibited satisfactory physicochemical characteristics with good stability and compatibility between the drug and excipients. All the pre-compression parameters, including angle of repose, bulk density, tapped density, Carr’s index, and Hausner’s ratio, were found to be within the acceptable IP limits, indicating good flow and compressibility properties of the powder blend. Similarly, all post-compression parameters such as hardness, friability, weight variation, thickness, drug content, and in-vitro drug release were also found to comply with IP standards. Among all the formulations, F4 formulation was considered as the optimized formulation based on its superior evaluation parameters and drug release profile. The F4 formulation showed a maximum cumulative drug release of 98.41% over a period of 48 hours when compared to other formulations, indicating an effective sustained-release behaviour and better formulation performance. Thus, the developed Fulvestrant Solid Lipid Nanoparticle formulation demonstrated enhanced drug release characteristics and may improve the bioavailability and therapeutic efficacy of Fulvestrant. The study concludes that SLNs are a promising and efficient carrier system for the controlled delivery of Fulvestrant and can be further explored for advanced pharmaceutical applications.
Keywords: Fulvestrant Solid Lipid Nanoparticle

Cite This Article:

Please cite this article in press Maddela Bharani et al., Formulation And Evaluation Of Saxagliptin-Loaded Transferosomal Oral Thin Films For Enhanced Permeability.,. Indo Am. J. P. Sci, 2026; 13(11)..

REFERENCES:

1. Remington ‘The science and practice of pharmacy’ 20th edition, VOL I: 903-905, 2001.
2. Y.W. Chien, Drug Development And Industrial Pharmacy 1983, 9: 447-520, 1291-1330.
3. F. Teewes, Drug Development And Industrial Pharmacy 1983,9: 1331- 1357.
4. J. M. Class., R.L.Stephan and S. C. Jacobson, Int. j. Dermatol, 19:519.
5. H.Sezahi and M. Hashida, Crc, Critical Reviews In “Therapeutic drug Carrier Systems”, 1984, 1:1.
6. T.A Horbett, B.D Ratner, T.Kost and M.Sigh In “ Recent Advances In Drug Delivery System” Plenum Press, New york. 1984, 209-220.
7. Joseph R. Robinson., Vincent H.L. Lee, “Controllrd Drug Delivery”, 2nd edition, revised and expanded, 1987: 596-597.
8. S. P. Vyas, R.K. Khar. “Targeted and Controlled Druig Delivery Novel Carrier Systems”, I edition, CBS Publishers, New Delhi, 2002: 39-40, 42-46.
9. Welling pG, Dobrinska MR, In Robinson JR, Lee VHL, eds: “Controlled Drug Delivery”, II edition, Marcel Dekker, New york.1987: 253.
10. Gregoriadis G, “Targeting of drugs”, Nature. 1977: 407-411.
11. Gregoriadis G. In Gregoriadis C, Senior J, Trout A, eds: “Targeting of drugs”, Plenum, New york. 1982: 155.
12. Tretise A, D.M. Brahmankhar, Sunil B. Jaiswal, “Biopharmaceutics and Pharmacokinetics”, 2001: 360-363.
13. Wirth M, Hamilton G and Gabar F, “J.Drug Target”, 6, 1998: 95-104.
14. Subheet Jain, Dipankar Bhadra, N. K. Jain. (2001)”Advances in Controlled and Novel Drug Delivery” 1st edition, CBS Publishers, New Delhi, 427.
15. Christophers, e.; Walff, H. H; Laurence, E.B. (1974) “The formation of epidermal cell columns”, J. Invest. Dermatol., 62: 556-564.
16. Christophers, E.91988) In: The Skin of vertebrates, Spearman, R. I.C. ; Riley, P.A; (Eds.0, Academic Press, London, 137-139.
17. Juliano, R. L. (1980) “Drug Delivery Systems”. Oxford university press. New york, 15.
18. Prausnitz, M. R. ; Allen, M. G. (1998) J. Pharm. Sci., 87(8): 925
19. Chowdary, K. P. R.; Naidu, R. A. S. (1995)”Transdremal drug delivery; areview of current status”, Indian Drugs, 32(9): 414-422.
20. Barry, B. W. (1991)”LPP theory of Skin penetration enhancement”, J. Control. Rel., 15: 237-248.